UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...

UnitedHealth Group (NYSE: UNH) provided updates on its 2025 annual shareholder meeting and actions taken by its Board of ...

We came across a bullish thesis on UnitedHealth Group Incorporated (UNH) on FluentInQuality’s Substack. In this article, we ...

UnitedHealth Group prepared talking points for its shareholder meeting this week. The company published them Wednesday after ...

A spokesperson for UnitedHealth Group said. "The Guardian refused to engage with the truth and chose instead to print its ...

US insurance behemoth UnitedHealth Group is suing The Guardian for defamation weeks after ... Among the accusations The Guardian played up was the fact that UnitedHealth and its Optum arm offered ...

With a price target of $377, analysts from the Bernstein SocGen Group reiterated their Outperform rating on UnitedHealth ...

UnitedHealth said that Hemsley intends to stay on as CEO for at least three years. Its governance committee reviews and ...

UnitedHealth added 800,000 Medicare Advantage members in Q1 FY 2025. Click here to find out why UNH stock is a Buy.

UnitedHealthcare and Optum's struggles with an evolving Medicare Advantage market have investors questioning if valued-based care companies are at risk.

UnitedHealthcare sued The Guardian on Wednesday for defamation, claiming the British daily ran information it knew to be ...

Stephen Hemsley previously served as CEO from 2006 through 2017 and has chaired the UnitedHealth Group board since 2017.